Developer docs
API playgroundTry for free, no card

Search company profiles

Rahko

Full company profile

uuid0002wc8

Namestring
Rahko
Legal namestring
Rahko
Websiteurl
rahko.ai
Company typeenum
Private
Founded yearint
2019
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
quantum machine learning, computational chemistry software, quantum chemistry simulation, chemical property prediction, drug discovery software
Industry5 codes
SECONDARYHDAGADAA
Quantum Chemistry & Materials Modeling
Hardware, Technology & Telecom/Quantum Computing/Quantum Algorithms & Application Development
SECONDARYHDAGAEAB
Pharmaceutical & Biotech R&D Simulation (drug discovery, protein/ligand)
Hardware, Technology & Telecom/Quantum Computing/Quantum Simulation & Digital Twins
SECONDARYHDAGADAG
Quantum Simulation Algorithms (Dynamics, Monte Carlo, Lattice Models)
Hardware, Technology & Telecom/Quantum Computing/Quantum Algorithms & Application Development
SECONDARYHDAGACAB
Quantum Development Frameworks & Libraries
Hardware, Technology & Telecom/Quantum Computing/Quantum Software, SDKs & Development Tools
SECONDARYHDAGANAG
Hybrid Systems Benchmarking, Profiling & Observability
Hardware, Technology & Telecom/Quantum Computing/Hybrid Quantum-Classical Systems (Integration with Traditional Computing)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
Product category
Quantum Computing Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Enterprise Software Licenses / Platform Access
TypeSubscription Recurring
Description

Rahko offers its quantum machine learning platform to enterprise customers for chemical simulation. Revenue likely derives from platform/software licensing to large companies in pharma and materials science, with multi-year contracts evidenced by the 3-year Merck collaboration.

rahko.ai
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Rahko develops a quantum machine learning platform for solving chemistry problems, including prediction of chemical properties, molecular excited states, and density functional theory computations. The platform integrates with classical HPC and quantum hardware (IBMQ, Honeywell, Pasqal, Amazon Braket), delivering speedups up to 5 orders of magnitude over traditional methods for pharmaceutical and materials science applications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Speedups up to 5 orders of magnitude over traditional chemical simulation methods
+1 more record
Product overview1 text field

Rahko offers a unified quantum machine learning platform for chemical simulation, combining classical computing solutions with quantum computing capabilities. The core product is the Rahko Quantum Machine Learning Platform, which includes proprietary algorithms such as the Discriminative Variational Quantum Eigensolver for molecular excited states computation, parametrized quantum circuits trained like deep learning models, and quantum error correction methods. The platform delivers speedups up to 5 orders of magnitude for predicting chemical properties and is designed to integrate with quantum computers as they scale to practical applications.

Product and service3 records
1Rahko Quantum Machine Learning Platform
CategoryCore Platform
Description

A quantum machine learning platform that enables accurate prediction of chemical properties at speeds up to 5 orders of magnitude faster than traditional methods. Integrates with classical HPC and quantum computing infrastructure (IBMQ, Honeywell, Pasqal, Amazon Braket) and is designed for enterprise customers in pharmaceutical and materials science industries.

2Discriminative Variational Quantum Eigensolver (DVQE)
CategoryQuantum Chemistry Algorithm
Description

A quantum algorithm for computing molecular excited states on quantum hardware, developed for quantum chemistry applications. Built for enterprise research teams running simulations on real quantum processors.

3Large-Scale Density Functional Theory (DFT) on Cloud HPC
CategoryCloud HPC Chemistry Service
Description

An efficient, large-scale Density Functional Theory computation capability delivered via cloud-based high-performance computing infrastructure, enabling materials simulation for enterprise customers.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2020-08-01
Description

Rahko integrated with Amazon Braket, AWS's quantum computing service. Rahko was featured in AWS's announcement of General Availability of Amazon Braket in August 2020. As part of the Innovate UK Quantifi project, Rahko and Johnson Matthey used AWS for efficient large-scale DFT on the cloud.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-06-01
Description

Pasqal and Rahko announced a 2-year collaborative project co-funded by Région Ile de France, as part of the Innov'up Leader PIA programme. The project involves jointly developing algorithms for quantum chemistry on Pasqal's neutral-atom quantum hardware.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-05-01
Description

Rahko announced a 3-year collaboration with Merck (the science and technology company), focused on exploring and leveraging quantum inspired machine learning for drug discovery and development. This is a formal co-development partnership representing Rahko's primary commercial engagement.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

Innovate UK awarded a grant to a Rahko-led consortium for the world's first project to simulate complex materials on near-term quantum computers. The consortium includes technology, industry, and academia experts. Rahko, Johnson Matthey, and AWS jointly demonstrated efficient large-scale Density Functional Theory on cloud HPC as part of project Quantifi.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

Johnson Matthey participated as an industry partner in the Innovate UK Quantifi project led by Rahko, working alongside AWS to demonstrate efficient, large-scale Density Functional Theory on the cloud.

6IBMQ
Strategic tierCoreTypeTechnology or Integration
Description

Rahko partners with IBMQ, one of the world's largest quantum hardware manufacturers. Rahko has published research on computation of molecular excited states using IBMQ hardware and has integrated its platform with IBMQ systems.

rahko.ai
Strategic tierCoreTypeTechnology or Integration
Description

Rahko partnered with Honeywell Quantum Solutions (trapped-ion quantum hardware manufacturer), achieving groundbreaking accuracy benchmarks on Honeywell's QPU 'System Model H0'.

8Quantum Biology Network (QBN)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Rahko is listed as a member of the Quantum Biology Network (QBN), indicating participation in a quantum technology ecosystem/network.

rahko.ai
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Xanadu is a quantum computing company building both photonic hardware and a quantum software stack, with explicit focus on quantum chemistry and machine learning applications. It directly overlaps with Rahko's QML-for-chemistry platform and competes for the same enterprise customers in pharma and materials.

TypeDirect peer
Description

Zapata (now Quantum Generative Materials) develops quantum algorithms and Orquestra, a quantum workflow platform targeting chemistry, materials, and finance use cases. It competes head-to-head with Rahko on quantum ML software for molecular simulation.

TypeDirect peer
Description

QC Ware is a quantum software company that builds enterprise-facing algorithms, including chemistry and materials simulation modules, deployable across multiple quantum hardware backends. It overlaps directly with Rahko's platform strategy and pharma customer base.

TypeBroad incumbent
Description

Quantinuum, formed from the merger of Honeywell Quantum Solutions and Cambridge Quantum, operates a full-stack trapped-ion quantum platform with significant quantum chemistry software (InQuanto). As Rahko's former Honeywell partner and a vertically integrated competitor, it is a broad incumbent pressure on Rahko's chemistry stack.

5QunaSys
TypeDirect peer
Description

QunaSys is a quantum chemistry software specialist offering Quri Chemistry and related algorithmic tools to enterprise pharma and chemicals customers. It is one of the closest direct competitors to Rahko in the quantum-for-chemistry niche.

6HQS Quantum Simulations
TypeDirect peer
Description

HQS Quantum Simulations is a German quantum software company focused on materials and chemistry simulation for industrial customers. It targets the same pharmaceutical and materials science buyers as Rahko with comparable hybrid quantum-classical approaches.

TypeDirect peer
Description

Multiverse Computing applies quantum and quantum-inspired algorithms to chemistry, materials, and finance. Its Singularity and QuantumSaaS platforms overlap with Rahko's enterprise quantum chemistry offering, particularly for materials and chemistry clients.

TypeEmerging player
Description

Classiq provides a high-level quantum software development platform focused on algorithm synthesis across hardware backends. While broader than Rahko's chemistry focus, it competes for the same enterprise software budgets and engineering attention.

TypeBroad incumbent
Description

IBM Quantum is one of Rahko's named platform partners (IBMQ) and a broad incumbent that also develops quantum chemistry tools (Qiskit Nature). Its dual role as enabler and competitor shapes Rahko's economics on IBM hardware.

TypeEmerging player
Description

Pasqal is a neutral-atom quantum hardware manufacturer partnered with Rahko since June 2020. While primarily a hardware play, Pasqal is developing its own chemistry and algorithms stack and represents both a partner and a potential future competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles19 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rahko

Quantum Computing Softwarerahko.ai

Rahko firmographics

Firmographics
Name
Rahko
Legal name
Rahko
Website
https://rahko.ai
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Where Rahko is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Rahko business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Enterprise Software Licenses / Platform Access: Rahko offers its quantum machine learning platform to enterprise customers for chemical simulation. Revenue likely derives from platform/software licensing to large companies in pharma and materials science, with multi-year contracts evidenced by the 3-year Merck collaboration.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Rahko product offering

Product offering

Core offering

Rahko develops a quantum machine learning platform for solving chemistry problems, including prediction of chemical properties, molecular excited states, and density functional theory computations. The platform integrates with classical HPC and quantum hardware (IBMQ, Honeywell, Pasqal, Amazon Braket), delivering speedups up to 5 orders of magnitude over traditional methods for pharmaceutical and materials science applications.

Product overview

Rahko offers a unified quantum machine learning platform for chemical simulation, combining classical computing solutions with quantum computing capabilities. The core product is the Rahko Quantum Machine Learning Platform, which includes proprietary algorithms such as the Discriminative Variational Quantum Eigensolver for molecular excited states computation, parametrized quantum circuits trained like deep learning models, and quantum error correction methods. The platform delivers speedups up to 5 orders of magnitude for predicting chemical properties and is designed to integrate with quantum computers as they scale to practical applications.

Differentiator

Problem solved

Functional benefit

Products and services

  • Rahko Quantum Machine Learning Platform A quantum machine learning platform that enables accurate prediction of chemical properties at speeds up to 5 orders of magnitude faster than traditional methods. Integrates with classical HPC and quantum computing infrastructure (IBMQ, Honeywell, Pasqal, Amazon Braket) and is designed for enterprise customers in pharmaceutical and materials science industries.
  • Discriminative Variational Quantum Eigensolver (DVQE) A quantum algorithm for computing molecular excited states on quantum hardware, developed for quantum chemistry applications. Built for enterprise research teams running simulations on real quantum processors.
  • Large-Scale Density Functional Theory (DFT) on Cloud HPC An efficient, large-scale Density Functional Theory computation capability delivered via cloud-based high-performance computing infrastructure, enabling materials simulation for enterprise customers.

Quantifiable outcome

  • Speedups up to 5 orders of magnitude over traditional chemical simulation methods
  • +1 more outcomes

Companies that use Rahko

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Rahko technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature8 records

Rahko partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • Amazon Web Services (AWS) / Amazon BraketcoreTechnology or Integration · 1 August 2020Rahko integrated with Amazon Braket, AWS's quantum computing service. Rahko was featured in AWS's announcement of General Availability of Amazon Braket in August 2020. As part of the Innovate UK Quantifi project, Rahko and Johnson Matthey used AWS for efficient large-scale DFT on the cloud.
  • PasqalcoreStrategic or Co-development Partner · 1 June 2020Pasqal and Rahko announced a 2-year collaborative project co-funded by Région Ile de France, as part of the Innov'up Leader PIA programme. The project involves jointly developing algorithms for quantum chemistry on Pasqal's neutral-atom quantum hardware.
  • MerckcoreStrategic or Co-development Partner · 1 May 2020Rahko announced a 3-year collaboration with Merck (the science and technology company), focused on exploring and leveraging quantum inspired machine learning for drug discovery and development. This is a formal co-development partnership representing Rahko's primary commercial engagement.
  • Innovate UK (Quantifi Project Consortium)coreStrategic or Co-development Partner · 1 January 2020Innovate UK awarded a grant to a Rahko-led consortium for the world's first project to simulate complex materials on near-term quantum computers. The consortium includes technology, industry, and academia experts. Rahko, Johnson Matthey, and AWS jointly demonstrated efficient large-scale Density Functional Theory on cloud HPC as part of project Quantifi.
  • Johnson MattheycoreStrategic or Co-development Partner · 1 January 2020Johnson Matthey participated as an industry partner in the Innovate UK Quantifi project led by Rahko, working alongside AWS to demonstrate efficient, large-scale Density Functional Theory on the cloud.
  • IBMQcoreTechnology or IntegrationRahko partners with IBMQ, one of the world's largest quantum hardware manufacturers. Rahko has published research on computation of molecular excited states using IBMQ hardware and has integrated its platform with IBMQ systems.
  • Honeywell Quantum SolutionscoreTechnology or IntegrationRahko partnered with Honeywell Quantum Solutions (trapped-ion quantum hardware manufacturer), achieving groundbreaking accuracy benchmarks on Honeywell's QPU 'System Model H0'.
  • Quantum Biology Network (QBN)minorStrategic or Co-development PartnerRahko is listed as a member of the Quantum Biology Network (QBN), indicating participation in a quantum technology ecosystem/network.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Rahko competitors and assessment

Company assessment

Direct peers

  • Xanadu: Xanadu is a quantum computing company building both photonic hardware and a quantum software stack, with explicit focus on quantum chemistry and machine learning applications. It directly overlaps with Rahko's QML-for-chemistry platform and competes for the same enterprise customers in pharma and materials.
  • Zapata Computing: Zapata (now Quantum Generative Materials) develops quantum algorithms and Orquestra, a quantum workflow platform targeting chemistry, materials, and finance use cases. It competes head-to-head with Rahko on quantum ML software for molecular simulation.
  • QC Ware: QC Ware is a quantum software company that builds enterprise-facing algorithms, including chemistry and materials simulation modules, deployable across multiple quantum hardware backends. It overlaps directly with Rahko's platform strategy and pharma customer base.
  • QunaSys: QunaSys is a quantum chemistry software specialist offering Quri Chemistry and related algorithmic tools to enterprise pharma and chemicals customers. It is one of the closest direct competitors to Rahko in the quantum-for-chemistry niche.
  • HQS Quantum Simulations: HQS Quantum Simulations is a German quantum software company focused on materials and chemistry simulation for industrial customers. It targets the same pharmaceutical and materials science buyers as Rahko with comparable hybrid quantum-classical approaches.
  • Multiverse Computing: Multiverse Computing applies quantum and quantum-inspired algorithms to chemistry, materials, and finance. Its Singularity and QuantumSaaS platforms overlap with Rahko's enterprise quantum chemistry offering, particularly for materials and chemistry clients.

Broad incumbents

  • Quantinuum: Quantinuum, formed from the merger of Honeywell Quantum Solutions and Cambridge Quantum, operates a full-stack trapped-ion quantum platform with significant quantum chemistry software (InQuanto). As Rahko's former Honeywell partner and a vertically integrated competitor, it is a broad incumbent pressure on Rahko's chemistry stack.
  • IBM Quantum: IBM Quantum is one of Rahko's named platform partners (IBMQ) and a broad incumbent that also develops quantum chemistry tools (Qiskit Nature). Its dual role as enabler and competitor shapes Rahko's economics on IBM hardware.

Emerging players

  • Classiq: Classiq provides a high-level quantum software development platform focused on algorithm synthesis across hardware backends. While broader than Rahko's chemistry focus, it competes for the same enterprise software budgets and engineering attention.
  • Pasqal: Pasqal is a neutral-atom quantum hardware manufacturer partnered with Rahko since June 2020. While primarily a hardware play, Pasqal is developing its own chemistry and algorithms stack and represents both a partner and a potential future competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights7 records

Customer concentration

Rahko social profiles

Digital presence

Rahko financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rahko leadership team

Management profile

Number of profiles

Profiles19 records

Rahko funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rahko M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rahko

What does Rahko do?

Rahko develops a quantum machine learning platform for solving chemistry problems, including prediction of chemical properties, molecular excited states, and density functional theory computations. The platform integrates with classical HPC and quantum hardware (IBMQ, Honeywell, Pasqal, Amazon Braket), delivering speedups up to 5 orders of magnitude over traditional methods for pharmaceutical and materials science applications.

Is Rahko a public or private company?

Rahko is a private company. It is classified as venture growth investor backed and is currently operating.

When was Rahko founded?

Rahko was founded in 2019. It employs 11 to 50 people.

Where is Rahko based?

Rahko is headquartered in London, United Kingdom, in the Europe region.

How does Rahko make money?

One revenue line is on record: enterprise Software Licenses / Platform Access.

Who are Rahko's main competitors?

Direct peers on record are Xanadu, Zapata Computing, QC Ware, QunaSys, HQS Quantum Simulations and Multiverse Computing. Broad incumbents are Quantinuum and IBM Quantum. Emerging players are Classiq and Pasqal.

Does Rahko have an API?

No public API is recorded for Rahko.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Trust & Safety PoliciesRahko acquired by Odyssey TherapeuticsOdyssey Therapeutics acquired Rahko, a quantum machine learning company founded in 2018. Rahko's platform combines computational chemistry, machine learning, and quantum computing to accelerate drug discovery. The acquisition aims to speed up identification of leads for inflammatory diseases and cancer.PR NewswireOdyssey Therapeutics Acquires Rahko, a Quantum Machine Learning CompanyOdyssey Therapeutics acquired Rahko, a quantum machine learning company, to add physics-based molecular simulation and machine learning to its drug discovery platform. Rahko's platform combines computational chemistry, machine learning, and quantum computing to accelerate lead identification. The acquisition aims to speed up drug discovery for inflammatory diseases and cancer.BioSpaceQuantum ML Company Rahko Right Fit for Fast-Moving OdysseyOdyssey Therapeutics, which raised $218 million in a Series A round last month, acquired London-based Rahko for an undisclosed sum, with Rahko's team remaining in London. The acquisition adds quantum machine learning, computational chemistry and drug discovery capabilities to Odyssey's seven active programs in immunology and oncology. Glick expects the first asset to enter human testing in 2023 or early 2024, with up to 40 new hires planned.ThequantuminsiderOdyssey Therapeutics Acquires Quantum Drug Discovery Startup RahkoOdyssey Therapeutics acquired a majority stake in London-based Rahko, a quantum drug discovery startup, without disclosing the deal amount. Rahko develops Hyrax, a quantum computing service for drug discovery, and had raised $1.6 million in seed funding in 2019.The TelegraphQuantum drug discovery start-up Rahko snapped up by US investor Odyssey TherapeuticsUS investor Odyssey Therapeutics acquired a majority stake in London-based Rahko, a quantum computing start-up developing drug discovery software. Odyssey raised $218m in venture capital to back new drugs and discovery technologies. The acquisition follows similar moves by US investors in UK quantum companies.BusinessCloudQuantum computing firm to expand London teamQuantum machine-learning firm Rahko raised £1.3m in seed funding led by Balderton. The company will use the funds to expand its team of quantum experts to tackle bigger projects. It expects to recruit globally and aims to make quantum computers commercially usable.UktechnewsRahko secures £1.3 million Seed investment from Balderton CapitalRahko, a quantum machine learning company, raised a £1.3m seed round led by Balderton Capital. The funding will expand its expert team to advance quantum discovery for chemical simulation, with applications in batteries, materials, and drugs.TechCrunchRahko raises £1.3M seed from Balderton for quantum machine learning techRahko, a U.K. startup, raised £1.3 million in seed funding led by Balderton Capital. The company is building quantum machine learning for chemical simulation, aiming to accelerate quantum computer adoption. It plans to partner with IBM and Microsoft.